| 大剂量美能与贺普丁治疗慢性重型乙型肝炎的临床研究 |
| |
| 引用本文： | 黄献球.大剂量美能与贺普丁治疗慢性重型乙型肝炎的临床研究[J].蛇志,2004,16(4):16-18. |
| |
| 作者姓名： | 黄献球 |
| |
| 作者单位： | 广西桂东人民医院,广西,梧州,543001 |
| |
| 摘 要： | 目的 探讨应用大剂量美能与贺普丁能否阻断慢性重型乙型肝炎 (慢重肝 )病人病情的恶化。 方法 观察应用该疗法组 (联合组 ) ,并与普通组及单剂组比较慢重肝病人各项临床症状、体征、化验结果的变化。 结果 应用该疗法后能减轻慢重肝的临床症状与体征 ,降低病死率。与普通组及单剂组比较有显著性差异 (P <0 .0 5 )。 结论 大剂量美能与贺普丁治疗慢重肝疗效确切 ,降低了病死率 ,可推广应用。
|
| 关 键 词： | 治疗 美能 贺普丁 大剂量 慢性重型乙型肝炎 病死率 病人 推广应用 临床症状 单剂 |
| 文章编号： | 1001-5639(2004)04-0016-03 |
Clinical Study on A Great Dose of SNMC and Lamivudine Treat Chronic Severe Hepatitis B |
| |
| Huang Xian-qiu.Clinical Study on A Great Dose of SNMC and Lamivudine Treat Chronic Severe Hepatitis B[J].Journal of Snake,2004,16(4):16-18. |
| |
| Authors: | Huang Xian-qiu |
| |
| Abstract: | Objective Use a great dose of SNMC and La mi vudine to prevent chronic severe hepatitis. Methods 62 cases of chronic s ever e hepatitis were divided into three groups:commom group, single dose group amd c ombination group. Results There is a significant difference between commo m group and combination group. Combination group can prevent 71.4% of chronic severe hepatitis patient lead to die. Conclusion It is definite that a great dose of SNMC and lamivudine treat chronic severe hep atitis patient.It can prevent this sort of patient lead to die. |
| |
| Keywords: | SNMC Lamivudine chronic severe hepatitis |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
